immucor posts

Feed

Earnings Highlights: Borders, CarMax, LDK Solar, Mosaic, RIM, Rite Aid ...

Here are some highlights from this past week's earnings coverage on BloggingStocks:

  • Acuity Brands Inc. (AYI) Q2 results were essentially flat but an analyst's upgraded helped boost shares.
  • Borders Group Inc. (BGP) reported strong Q4 earnings due to cost cutting but revenue continued to decline.
  • Cal-Maine Foods Inc. (CALM) received an analyst's downgrade on valuation following release of its Q3 report.
  • CarMax Inc. (KMX) rose to a new 52-week high following better-than-expected Q4 earnings and sales results.
  • Charming Shoppes Inc. (CHRS) posted a smaller-than-expected Q4 net loss and said same-store sales declined.

Continue reading Earnings Highlights: Borders, CarMax, LDK Solar, Mosaic, RIM, Rite Aid ...

Immucor EPS Inch Higher in Q3, Beat Expectations

Wednesday after the closing bell, Norcross, Ga.-based Immucor Inc. (BLUD) reported a third-quarter net income of $20.1 million, or 28 cents per share, up from $19.5 million, or $0.27 per share, in the same quarter a year ago. Analysts polled by Thomson Reuters had expected earnings of $0.27 per share for the quarter, so this blood-test equipment maker manages to hang on to its streak of quarterly earnings beats.

Revenue for this quarter rose 7% from a year ago to $80.5 million, primarily due to price contributions and currency. But that fell just short of analysts' estimates of $80.9 million.

Continue reading Immucor EPS Inch Higher in Q3, Beat Expectations

The week in preview: Is the rally over?

Autumn has arrived and the quarter winds down this week. The Dow has been inching toward 10,000 for a while now, though it closed lower in the past three sessions. Can it make it to 10,000 for the start of the third quarter? If so, what will push it higher? If not, what will drag it down further?

Continue reading The week in preview: Is the rally over?

Immucor names a new Vice President and COO

Blood-transfusion leader Immucor (BLUD) introduced Geoffrey S. Crouse as the company's new Vice President and Chief Operating Officer. Crouse will have worldwide responsibility for manufacturing and distribution in the new position, he will also be responsible for marketing and customer service. In his previous position at Millipore Corporation, Crouse led the Life Science Strategic Business Unit - helping improve manufacturing operations, leading acquisitions, all the while increasing sales and profitability.

Continue reading Immucor names a new Vice President and COO

Immucor tops Q3 profit estimates and reaffirms FY 09 guidance

Immucor Inc. (NYSE: BLUD), a producer of blood-testing systems, reported Monday that thinner profit margins were offset by increased sales in its fiscal third quarter, resulting in a narrowly higher profit.

In the three months that ended Feb. 28, Immucor's net income increased to $19.5 million, or 27 cents per share, from $19.3 million in the same period of last year. Revenue rose 12% to $75.3 million. Analysts surveyed by Thomson Reuters had forecast a profit of 22 cents per share and $73.2 million in revenue.

Continue reading Immucor tops Q3 profit estimates and reaffirms FY 09 guidance

Immucor (BLUD): Two experts bank on blood bank buy

Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.

Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.

"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.

"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.

Continue reading Immucor (BLUD): Two experts bank on blood bank buy

The week in preview: End-of-quarter expectations

Even if the national headlines weren't already providing enough focus on the economy, plenty of economic data is due out as the month and the quarter wind down. U.S. economic data scheduled to be released this week include:

Other economic events scheduled for this week include:

Continue reading The week in preview: End-of-quarter expectations

Market highlights for next week: Monthly sales due out

Monday, June 2
Tuesday, June 3

Continue reading Market highlights for next week: Monthly sales due out

Earnings highlights: UBS, Best Buy, RIM, Monsanto, Family Dollar and others

As one quarter rolls over into the next, here are some highlights from this past week's earnings coverage from BloggingStocks:

Also, prospects look grim for some newspapers. The financial crisis in the U.S. prompted the IMF to cut its global growth forecast.

Upcoming results to watch for include Alcoa (NYSE: AA), Circuit City Stores (NYSE: CC), Bed Bath & Beyond (NASDAQ: BBBY), and General Electric (NYSE: GE).

Visit AOL Money & Finance for more earnings coverage.

Immucor (BLUD): Shares define bullish 'flag' pattern

Immucor (NASDAQ: BLUD) provides automated systems used by hospitals, clinical laboratories and blood banks to detect and identify certain properties of the cell and serum components of human blood prior to transfusion. Products are primarily used to type blood and detect foreign antibodies. Immucor sells its systems and reagent tests directly in North America, Western Europe and Japan.

The company made news earlier in the week, when it reported Q3 EPS of 27 cents and revenues of $67.3 million. Analysts had been looking for 22 cents and $62.9 million. Management also guided FY08 EPS to at least 96 cents (92 cent consensus) and FY08 revenues to at least $257 million ($255.89M consensus).

Continue reading Immucor (BLUD): Shares define bullish 'flag' pattern

Market highlights for next week: Consumer Electronics Show to be held in Las Vegas

Monday, January 4
Tuesday, January 5
Wednesday, January 6
Thursday, January 7
Friday, January 8

Immucor (BLUD): Upside potential for the maker of blood bank systems

Given the steady need for emergency and surgical transfusions, it's imperative that routine blood bank tests be performed quickly and accurately. A leading maker of systems that automate such work is headquartered in Norcross, Georgia.

Immucor (NASDAQ: BLUD) provides automated systems used by hospitals, clinical laboratories and blood banks to detect and identify certain properties of the cell and serum components of human blood, prior to transfusion. Products are primarily used to type blood and detect foreign antibodies. The firm received FDA clearance for its third-generation automated analyzer, the Galileo Echo, in June of this year.

Continue reading Immucor (BLUD): Upside potential for the maker of blood bank systems

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 11, 2012: 01:43 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328942605826 ms.